SUMMIT THERAPEUTICS ANNOUNCES CLINICAL TRIAL COLLABORATION WITH ASTRAZENECA AND DAIICHI SANKYO TO EVALUATE IVONESCIMAB IN COMBINATION WITH TROP2-DIRECTED ADC DATROWAY

Reuters · 3d ago

Please log in to view news